Explore

New Study Reveals BMI Misses Key Aspects of Obesity, Advocates for Broader Diagnostic Criteria

New Study Reveals BMI Misses Key Aspects of Obesity, Advocates for Broader Diagnostic Criteria

A multinational study involving over 844,000 adults from four cohorts, including the 'All of Us' Research Program in the United States, has found that Body Mass Index (BMI) alone often misclassifies obesity and its associated health risks. The research, published in Nature, suggests that incorporating waist circumference (WC) and waist-to-height ratio (WHtR) alongside BMI provides a clearer picture of obesity and its long-term health implications. The study differentiates between 'clinical obesity,' where excess adiposity impairs organ function, and 'preclinical obesity,' where excess adiposity exists without such impairment. It found that BMI-based classification overestimated obesity in some individuals and underestimated it in others, with combined anthropometric measures increasing overall obesity prevalence in the U.S. cohort by 5.6 percentage points. Clinical obesity was strongly associated with a 69% higher all-cause mortality hazard, while preclinical obesity had a 19% higher hazard.

NIH Grant Funds Expanded Research on Childhood Influences on Dementia Risk

NIH Grant Funds Expanded Research on Childhood Influences on Dementia Risk

University of Maryland researchers have secured a five-year, $3.16 million grant from the National Institutes of Health (NIH) to broaden a multi-institutional research network. This initiative, known as the Network on Early-Life Determinants, Biosocial Pathways and Dementia (EdDem), will investigate how early-life experiences, including childhood circumstances, family environments, and neighborhood conditions, influence the risk of dementia later in adulthood. The grant, administered by the National Institute on Aging, expands EdDem's initial focus on the relationship between education and dementia. The expanded research team will now explore the interactions between these early-life dynamics and adult factors such as socioeconomic status, health behaviors, inflammation, genetic susceptibility, and biological markers associated with Alzheimer’s disease. Professor Katrina Walsemann of the University of Maryland's School of Public Policy leads the project, co-led by Professor Pamela Herd of the University of...

Representative Jake Auchincloss Introduces 'Faster Clinical Trials Act' to Modernize Drug Development

Representative Jake Auchincloss Introduces 'Faster Clinical Trials Act' to Modernize Drug Development

U.S. Rep. Jake Auchincloss, D-Mass., has introduced H.R. 10857, known as the 'Faster Clinical Trials Act.' This comprehensive bill aims to accelerate medical research, enhance clinical trial efficiency, and strengthen oversight in drug development and labeling. Key provisions include establishing an FDA-led 'Cures in Care' program to facilitate routine clinical trials within standard healthcare settings, promoting decentralized methods, and prioritizing underserved populations. The bill also mandates more standardized data sharing for point-of-care trials, expands FDA and CMS guidance on trial funding, and updates oversight rules. Furthermore, it seeks to modernize the review of early-stage trials, align with international standards, and scrutinize foreign data used in FDA decisions. The legislation also proposes creating an FDA Rare Disease Innovation Hub to expedite rare disease trials and biomarker development. Additionally, it would establish an Oncology Center of Excellence and a new FDA process for r...

Personalized Medicine in Primary Care Emphasizes Tailored Prevention and Treatment in Tampa

Personalized Medicine in Primary Care Emphasizes Tailored Prevention and Treatment in Tampa

Personalized medicine in primary care is evolving to focus on tailoring prevention, screening, and treatment based on an individual's history, risk factors, goals, and circumstances, according to InCare. This approach does not inherently require genetic testing. While pharmacogenomic testing can inform medication choices, the FDA notes that for many gene-drug associations, the benefit to patients has not been established, and it should not replace clinical judgment. Patients are advised against using direct-to-consumer genetic test results alone for diagnosis or treatment changes, and should instead consult qualified clinicians for review. The core idea is to move beyond one-size-fits-all advice, with personalized care prioritizing prevention, risk analysis, and ongoing optimization over merely treating existing problems. This contrasts with traditional primary care, which often relies on general protocols.

Study Reveals Global Health AI Inequities Stem from Power Distribution, Not Just Algorithms

Study Reveals Global Health AI Inequities Stem from Power Distribution, Not Just Algorithms

A qualitative study published in BMC Medical Ethics indicates that the deployment of artificial intelligence (AI) in global healthcare systems risks exacerbating existing structural inequities rather than resolving them. The research found that the capacity of AI technologies to either bridge or widen health disparities is not primarily dependent on the sophistication of the algorithms themselves. Instead, the study concludes that outcomes are determined by the willingness of institutions, developers, and policymakers to redistribute the underlying power that governs the design, practical deployment, and overall governance of AI systems. The study highlights a significant gap between public expectations of AI mitigating disparities and the current focus of academic research, which often concentrates on technical issues like algorithmic bias and data limitations, neglecting upstream power structures and historical root causes of inequities.

AACR Conference Addresses Cancer Health Disparities with Focus on Actionable Solutions

AACR Conference Addresses Cancer Health Disparities with Focus on Actionable Solutions

The 19th AACR Conference on the Science of Cancer Health Disparities, held from October 18-21, focused on identifying and implementing actionable solutions to address persistent inequities in cancer care. Monica L. Baskin, PhD, Director and Jeanette and Eric Lipman Chair in Oncology of the VCU Massey Comprehensive Cancer Center, emphasized that while significant progress has been made in cancer screening, treatment, and prevention since the National Cancer Institute's establishment in 1937, these advancements have not benefited all populations equally. The conference highlighted strategies such as community health worker programs, which have proven cost-effective in increasing screening rates for breast, cervical, and colorectal cancers. Additionally, the importance of ensuring underrepresented populations participate in clinical trials was stressed, with Baskin noting their willingness to participate if asked. The discussion also touched upon the potential of artificial intelligence (AI) to identify regio...

European Partnership BE READY Strengthens Pandemic Preparedness Across 27 Nations

European Partnership BE READY Strengthens Pandemic Preparedness Across 27 Nations

The BE READY partnership, funded by the European Union's Horizon Europe program, is actively working to enhance Europe's preparedness for future global pandemics. This initiative involves 81 organizations across 27 countries, aiming to build a robust European research and innovation ecosystem capable of responding to health crises caused by infectious diseases. The core of the partnership's strategy is to establish and maintain an 'ever-warm' research ecosystem, which includes an EU-wide network of clinical research sites. These sites are designed to be ready for rapid activation during global health emergencies, ensuring a swift and coordinated response. The partnership emphasizes strengthening the capacity to respond globally to immediate infectious disease threats, aligning with the broader objectives of the European Research Area (ERA). This collaborative effort seeks to address the critical need for preparedness highlighted by recent global health emergencies.

American Institutes for Research Launches 'AI in Health Network' to Study AI's Impact on Healthcare

American Institutes for Research Launches 'AI in Health Network' to Study AI's Impact on Healthcare

The American Institutes for Research (AIR) has initiated the 'AI in Health Network,' a collaborative research effort aimed at examining how artificial intelligence can enhance healthcare delivery, broaden access to services, and foster improved health outcomes. This network unites researchers, healthcare organizations, and technology developers globally through eight distinct projects. These projects will investigate AI applications within real-world healthcare environments, generating evidence to guide decisions regarding their implementation. The selected initiatives address a diverse array of health challenges, including advancements in cancer treatment, reduction of emergency department wait times, and expansion of access to vision care, HIV prevention, and nutrition services. The network's focus is on producing practical findings that can be utilized by healthcare providers, public health organizations, and policymakers. Brandy Farrar, an AIR Institute Fellow and lead of the AI in Health Network, emph...

Xavier Ochsner College of Medicine Opens New Center for Medical Education in New Orleans

Xavier Ochsner College of Medicine Opens New Center for Medical Education in New Orleans

Xavier Ochsner College of Medicine has celebrated the grand opening of its new Center for Medical Education in downtown New Orleans. The facility, located in Benson Tower, is designed to provide state-of-the-art learning environments for future medical professionals. It features modern classrooms, advanced laboratories, and collaborative spaces intended to foster interaction and teamwork among students and staff. This new center is a significant development for medical education in the region, aiming to enhance the training and development of healthcare providers. The facility is scheduled to welcome its first students in the summer of 2027, marking a new chapter for the institution and the local healthcare landscape.

African Institutions Urged to Lead Antimicrobial Resistance Research, Shape Next-Gen Antibiotics and Diagnostics

African Institutions Urged to Lead Antimicrobial Resistance Research, Shape Next-Gen Antibiotics and Diagnostics

African institutions are called upon to play a leading role in antimicrobial resistance (AMR) research, influencing the development and testing of next-generation antibiotics and diagnostics. The World Health Organization's 2025 assessments highlighted ongoing gaps in antibacterial innovation, pediatric formulations, and oral treatments, as well as limited simple diagnostic tools for primary and secondary care. The article emphasizes that surveillance data, such as that from Kenya and Rwanda's expanded Global Antimicrobial Resistance and Use Surveillance System (GLASS), should inform target product profiles for new medical tools. It advocates for African institutions to help define research questions, select meaningful outcomes, and interpret site-specific differences, ensuring that new products are designed for the conditions in which they will be used.

Precision Medicine Advances with Focus on Individualized Treatments and Genetic Data

Precision Medicine Advances with Focus on Individualized Treatments and Genetic Data

Precision medicine is an evolving field that utilizes advanced tools and technologies to customize medical treatments for individual patients. This approach considers a patient's unique genetic, environmental, and lifestyle profiles. By analyzing genetic data, medical researchers are developing targeted treatments that aim to be more effective than conventional, generalized medicines. Researchers are actively exploring new avenues within precision medicine, including genetic testing and personal genomics. The field is also addressing the challenge of scaling highly personalized therapies beyond single patients, drawing parallels with existing precision medicine models in oncology. The Precision Medicine World Conference (PMWC) Pioneer Award highlights research contributing to new cancer treatment options, emphasizing a continuous cycle of measurement, learning, and refinement to enhance the safety, practicality, and patient burden of new treatments.

Proposed Overhaul of U.S. Child and Adolescent Immunization Schedule Raises Concerns Over Insurance Coverage and Vulnerable Populations

Proposed Overhaul of U.S. Child and Adolescent Immunization Schedule Raises Concerns Over Insurance Coverage and Vulnerable Populations

A proposed overhaul of the U.S. child and adolescent immunization schedule, currently held up in federal court, could significantly reduce the number of recommended vaccines from 17 to 11. This change would re-categorize some vaccines, recommending them only for high-risk children or allowing them through shared clinical decision-making between providers and patients. A state official highlighted that if this overhaul becomes reality, it could have substantial implications for insurance coverage. Health plans are currently mandated to cover vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) and approved by the CDC director. If a vaccine is no longer officially recommended, health plans may not be required to cover it, potentially impacting population health. Furthermore, the Vaccines for Children (VFC) program, which provides vaccines to uninsured, underinsured, Medicaid-eligible, and American Indian/Alaska Native children, only covers ACIP-recommended immunizations. A reductio...